Jci_page_head_homepage_01 Jci_page_head_homepage_02
Rana K. Gupta, Marko Z. Vatamaniuk, Catherine S. Lee, Reed C. Flaschen, James T. Fulmer, Franz M. Matschinsky, Stephen A. Duncan, Klaus H. Kaestner
Published in Volume 115, Issue 4
J Clin Invest. 2005; 115(4):1006–1015 doi:10.1172/JCI22365
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

HNF-4α is not required for the maintenance of islet architecture or β cell mass. (AD) Immunofluorescence detection of the pancreatic hormones insulin, glucagon, and somatostatin, which label β cells, α cells, and δ cells, respectively. Similar to controls (A and C), 3- to 5-month-old HNF-4αloxP/loxP; Ins.Cre mice contain glucagon-positive α cells (B) and somatostatin-positive δ cells (D). In addition, insulin-positive β cells are centrally located in the islets of both controls and mutants, while less-frequent α cells and δ cells are found along the periphery (AD), indicating normal islet architecture in the HNF-4αloxP/loxP; Ins.Cre mice. Magnification, ×200. (E) Point-counting morphometry of 4-month-old mice reveals no significant difference in β cell mass between controls and mutants (control, 0.93 ± 0.17 mg, n = 6; mutant = 1.04 ± 0.22 mg, n = 5; P = NS).